| Literature DB >> 23527706 |
Y Shaik, G Sabatino, G Maccauro, G Varvara, G Murmura, A Saggini, M Rosati, F Conti, E Cianchetti, A Caraffa, P Antinolfi, F Pandolfi, G Potalivo, R Galzio, P Conti, T C Theoharides.
Abstract
IL-36 is another family member of IL-1 and induces the production of proinflammatory cytokines and activates MAPK and NFkB pathways. IL-36 is a common mediator of innate and adaptive immune response and is inhibited by IL-36 receptor antagonist (RA). IL-36RA acts on IL-36 receptor ligand which exerts proinflammatory effect in vivo and in vitro. IL-38 binds to IL-36 receptor as does IL-36RA and has similar biological effects on immune cells. IL-38 is also a member of IL-1 cytokine and shares some characteristics of IL-1RA, binding the same IL-1 receptor type I. IL-38 plays a role in the pathogenesis of inflammatory diseases, exerting protective effect in some autoimmune diseases. Both IL-38 and IL-36RA have an anti-inflammatory biological effect, however in some cases have contrary effects.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23527706 DOI: 10.1177/039463201302600103
Source DB: PubMed Journal: Int J Immunopathol Pharmacol ISSN: 0394-6320 Impact factor: 3.219